Bayesian Capital Management, LP Novartis Ag Transaction History

Bayesian Capital Management, LP

$582 Million
Q1 2025

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $379,537 - $440,217	4,100 Added 38.68%	14,700 $1.56 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $1.01 Million - $1.15 Million	10,600 New	10,600 $1.03 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $1.58 Million - $1.84 Million	-19,800 Reduced 54.11%	16,793 $1.54 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $725,280 - $888,192	9,600 Added 35.56%	36,593 $3.32 Million
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $2.01 Million - $2.36 Million	26,993 New	26,993 $2.05 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $1.34 Million - $1.56 Million	-16,617 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $1.33 Million - $1.51 Million	16,617 New	16,617 $1.46 Million
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $563,118 - $681,123	-7,213 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$82.14 - $91.0 $592,475 - $656,383	7,213 New	7,213 $627,000
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $494,548 - $692,871	-6,998 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $1.74 Million - $1.96 Million	-20,600 Reduced 74.64%	6,998 $663,000
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $1.91 Million - $2.1 Million	22,300 Added 420.91%	27,598 $2.4 Million
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $399,469 - $491,654	5,298 New	5,298 $484,000
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $338,939 - $387,675	-4,500 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $331,470 - $369,090	4,500 New	4,500 $386,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $723,755 - $837,173	-10,812 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$64.91 - $73.36 $676,037 - $764,044	-10,415 Reduced 49.06%	10,812 $817,000
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $1.49 Million - $1.79 Million	21,227 New	21,227 $1.72 Million
Q4 2017 Feb 12, 2018	SELL	$72.33 - $77.64 $949,475 - $1.02 Million	-13,127 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $973,235 - $1.01 Million	13,127	13,127 $1.13 Million

Others Institutions Holding NVS

# of Institutions

1,523

Shares Held

142M

Call Options Held

1.63M

Put Options Held

1.82M

Dodge & Cox San Francisco, CA

11.8M
Shares

$1.39 Billion
0.81% of portfolio
Primecap Management CO Pasadena, CA

10.4M
Shares

$1.22 Billion
0.98% of portfolio
Dimensional Fund Advisors LP Austin, TX

8.61M
Shares

$1.01 Billion
0.25% of portfolio
Morgan Stanley New York, NY

7.06M
Shares

$831 Million
0.06% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

6.76M
Shares

$797 Million
0.33% of portfolio

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $253B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account